tbuckley/cabot-search huggingface dataset:
List of Contributors
Authors: H.F. Ellenberger, Elisabeth Croufer-North, Hannelore Bobon-Schrod, Jacques Fraipont, M. Laxenaire, M. Mitscherlich, J. Cosnier, Helmut Enke, Claude Bloch, Andre Haynal, Irena Braun, Stanislaw Grochmal, P. Jonckheere, P. van Meerbeeck, Miguel A. Leibovich, F.E. Mairlot, Jacques Launay, M. Laxenaire, P. Bour, J.A.C. Bleeker, Mélinée Agathon, Ellen Corin, H. Schaffer, M. Nicolle, J.C. Archambault, P. Fouquet, L. Lasselin, Jerome D. Frank, Jacques Cain, R. Misés, M.J. Bailly-Salin, P. Sivadon, Cavin P. Leeman, Sharon Autio, Jean-Marie Delacroix, Milan Popović, N.N. Dracoulidès, Gilbert Pinard, Jacques Darquey, Michel de Boucaud, Alfredo Tridenti, Malkah T. Notman, Carol C. Nadelson, Mona B. Bennett, Marie-Aimée Guilhot, P. Caillé, L. Kaufmann, O. Masson, D. Masson, E. Fivaz, G. Basecqz, Clarice J. Kestenbaum, Harley C. Shands, J. Bastiaans, H.M. van der Ploeg, Mario Berta, Joseph Wolpe, D.R. Henny, Jerzy W. Aleksandrowicz, Edgar Heim, Einar Johnsen, Claudine Lilienfeld, Helga Stauffacher, Patrik Wirz, C. Bardet-Giraudon, Jorge E. Garcia Badaracco, Daniel Schurmans, H.O. Badura, E.M. Steinmeyer, Anne Cain, H. Davanloo, C. Benoit, H. Davanloo, Astrid Heiberg, E. Gillieron, Robert Dauteuil, Louis Faurobert, J. Rainaut, Jean M. Sutter, Jacqueline Falguière, Claude Ouzilou, P. Dubor, Owen S. Robbins, Peter E. Sifneos, A.A. Dahl, C.-I. Dahl, Astrid Heiberg, Ragnhild Husby, O.M. Olafsen, Tom Sørensen, L. Weisaeth, Jacqueline Verdeau-Pailles, H. Iwai, A. Homma, H. Amamoto, M. Asakura, Francesco Parenti, P.-B. Schneider, Finn Magnussen
Journal: Psychotherapy and Psychosomatics (1978)
CC-BY Open Access Added
Authors: Xiang-Dong Wu, Timothy Bhattacharyya, Marian Hannan, Douglas Kiel
Journal: JAMA Internal Medicine (2021)

Catherine R. Butler, MD, MA; Aaron Wightman, MA, MD; Claire A. Richards, RN, PhD; Ryan S. Laundry, BS; Janelle S. Taylor, PhD; Paul L. Hebert, PhD; Chuan-Fen Liu, PhD; Ann M. O’Hare, MD, MA
Obstetrical and Perinatal Outcomes in Female Survivors of Childhood and Adolescent Cancer: A Population-Based Cohort Study
Authors: Alina Zgardau, Joel G Ray, Nancy N Baxter, Chenthila Nagamuthu, Alison L Park, Sumit Gupta, Paul C Nathan
Journal: JNCI Journal of the National Cancer Institute (2022)

The likelihood of pregnancy and risk of obstetrical or perinatal complications is inadequately documented in female survivors of pediatric cancer.We assembled a population-based cohort of female survivors of cancer diagnosed at age 21 years and younger in Ontario, Canada, between 1985 and 2012. Survivors were matched 1:5 to women without prior cancer. Multivariable Cox proportional hazards and modified Poisson models assessed the likelihood of a recognized pregnancy and perinatal and maternal complications.A total of 4062 survivors were matched to 20 308 comparisons. Median (interquartile range) age was 11 (4-15) years at cancer diagnosis and 25 (19-31) years at follow-up. By age 30 years, the cumulative incidence of achieving a recognized pregnancy was 22.3% (95% confidence interval [CI] = 20.7% to 23.9%) among survivors vs 26.6% (95% CI = 25.6% to 27.3%) among comparisons (hazard ratio = 0.80, 95% CI = 0.75 to 0.86). A lower likelihood of pregnancy was associated with a brain tumor, alkylator chemotherapy, cranial radiation, and hematopoietic stem cell transplantation. Pregnant survivors were as likely as cancer-free women to carry a pregnancy >20 weeks (relative risk [RR] = 1.01, 95% CI = 0.98 to 1.04). Survivors had a higher relative risk of severe maternal morbidity (RR = 2.31, 95% CI = 1.59 to 3.37), cardiac morbidity (RR = 4.18, 95% CI = 1.89 to 9.24), and preterm birth (RR = 1.57, 95% CI = 1.29 to 1.92). Preterm birth was more likely in survivors treated with hematopoietic stem cell transplantation (allogenic: RR = 8.37, 95% CI = 4.83 to 14.48; autologous: RR = 3.72, 95% CI = 1.66 to 8.35).Survivors of childhood or adolescent cancer are less likely to achieve a pregnancy and, once pregnant, are at higher risk for severe maternal morbidity and preterm birth.
Abstract 285: Osteopontin Deficiency Ameliorates Heart Failure with Preserved Ejection Fraction &lt;HFpEF&gt; Pathology by Upregulating Mitochondrial 2-Oxoglutarate Dehydrogenase Like &lt;OGDHL&gt; Enzyme
Authors: Keyvan Yousefi, Wen Ding, Lina A Shehadeh
Journal: Circulation Research (2017)

HFpEF is an increasingly prevalent syndrome associated with impaired myocardial energetics, for which no etiologic therapy is available. Osteopontin (OPN) is a matricellular protein that is upregulated in the circulation of HFpEF patients, and reported to induce mitochondrial stress in rodent cardiomyocytes. Here we evaluate the role of circulating OPN in regulating myocardial function in the nephrotic Col4a3 -/- mouse model of HFpEF. We performed extensive cardiac, biochemical and mitochondrial analyses of the Col4a3 -/- mouse and found a striking HFpEF phenotype. We showed OPN levels were elevated in Col4a3 -/- mice (FC=2.1, n=6; p&lt;.01). Col4a3 -/- mice were hypertensive, had diastolic dysfunction, myocyte hypertrophy and interstitial fibrosis - all of which were ameliorated in Col4a3 -/- OPN -/- mice (n=5-20; p&lt;.05). Col4a3 -/- hearts had dysmorphic mitochondria (EM), lowered antioxidant capacity as a 50% reduction in GSH/GSSG ratio (n=6; p&lt;.05) and lower protein levels of mitochondrial respiratory complexes I, II and IV (p&lt;.05). Flux assay in adult cardiomyocytes showed that maximal respiration was reduced in Col4a3 -/- hearts (575.84±37.6 vs 322.34±25.48 pmol/min in WT, n=9; p&lt;.0001). Microarray data (validated by mitochondrial blot) implicated OGDHL as decreased in Col4a3 -/- hearts but increased in double knockout Col4a3 -/- OPN -/- hearts compared to WT (n=3; p&lt;.05). OGDH activity was also lower in Col4a3 -/- hearts (17.1±7.3 vs 2.5±1.1 mU/mg in WT; n=6; p&lt;.05). In Col4a3 -/- mice, heart-specific AAV9-mediated overexpression of OGDHL, similar to global OPN KO, improved survival by ~50-100% (p&lt;.0001). Isovolumetric relaxation time, a marker of diastolic dysfunction, which is prolonged in Col4a3 -/- mice (26.17 vs 15.30±1 ms, n=26; p&lt;.001) was decreased in Col4a3 -/- OPN -/- mice (18.1±1 ms, n=37; p&lt;.01) as well as in AAV9-cTnT-OGDHL-treated Col4a3 -/- mice (16.7±2.5 ms, n=8; p&lt;.05). In conclusion, we present a new mouse model for HFpEF in which diastolic function and lifespan can be improved by genetic deletion of OPN or cardiac OGDHL gene therapy. Our results elucidate for the first time the pivotal roles of circulating OPN and cardiac OGDHL in HFpEF pathophysiology and present two related potential therapeutic targets for HFpEF.
Abstract P250: Insulin Resistance During Pregnancy is Inversely Associated With Gynoid Fat Distribution Postpartum
Authors: Katherine H Ingram, Roxanna Lopez
Journal: Circulation (2018)

An association between abdominal adiposity and insulin resistance is well-established. Recent research indicates that subcutaneous fat accumulation in the lower body may be associated with higher levels of insulin sensitivity. Hypothesis: This pilot study tested the hypothesis that the distribution of body fat in the lower body after pregnancy is negatively associated with gestational insulin resistance. Methods: In 32 nulliparous pregnant women (age 27±4.5, BMI 29.5±7.9, 69% non-hispanic white), the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) was computed from fasting glucose and insulin at 24-28 weeks gestation. Body composition was assessed at mid-gestation (18-20 weeks) and at four weeks post-partum. Total body fat was estimated via bioelectrical impedance (InBody 720) and skinfold thicknesses were measured at seven sites. Dual-energy xray absorptiometry (DXA) measures of regional fat (gynoid, visceral, and leg) were obtained post-partum only. Gestational weight gain was monitored by medical records. Partial correlation analyses were controlled for age and race and then analyses were repeated controlling for baseline (mid-gestation) body fat percent. HOMA-IR was log-transformed for normality. Results: HOMA-IR was associated with post-partum body fat ( r =0.45, p &lt; .05) and adiposity in the trunk region ( r =0.58, 0.57 and 0.52 for DXA visceral fat, suprailiac skinfold, and abdominal skinfold, respectively, p &lt; .01), but not with gestational weight gain ( r =.07, p = ns), DXA gynoid region ( r = 0.26, p = ns), or any other leg measure. When analyses were further controlled for baseline body fat, post-partum measures of lower-body adiposity were strongly and negatively correlated with HOMA-IR ( r = -0.66, -0.48, and -0.48 for thigh skinfold, DXA gynoid, and DXA leg, respectively, p &lt; .05 for all). Neither DXA visceral fat ( r = .23; p = ns) nor any other post-partum fat measures were associated with HOMA-IR when controlling for baseline body fat. Conclusions: Gestational insulin resistance was negatively associated with post-partum thigh fat accumulation, independent of overall body fat. These data indicate that insulin sensitivity may be associated with the ability to store fat in the lower body and should warrant further study of subcutaneous leg fat as a metabolically “healthy” storage depot.
Reply
Authors: Emmanouil S. Brilakis, Christopher Lichtenwalter, James A. de Lemos, Michele Roesle, Owen Obel, Donald Haagen, Bilal Saeed, Chiranjeevi Gadiparthi, Joseph K. Bissett, Rajesh Sachdeva, Vassilios V. Voudris, Panagiotis Karyofillis, Biswajit Kar, James Rossen, Panayotis Fasseas, Peter Berger, Subhash Banerjee
Journal: Journal of the American College of Cardiology (2009)
Abstract 319: Role of Phosphodiesterases 4B and 4D in cAMP Signal Compartmentation Around Calcium Handling Proteins
Authors: Axel E Kraft, Viacheslav O Nikolaev, Marco Conti
Journal: Circulation Research (2017)

Phosphodiesterase subfamilies 4B and 4D are critically involved in the regulation of cAMP signaling in mammalian cardiomyocytes. Alterations in activity of these enzymes in human hearts have been shown to result in arrhythmia and heart failure. The aim of this project was to systematically investigate specific roles of PDE4B and PDE4D in regulating cAMP dynamics in three distinct subcellular microdomains formed around Ca 2+ handling proteins, such as L-type calcium channels (LTCCs), sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA) and ryanodine receptors (RyRs), to understand their impact on heart function and disease. Transgenic mice expressing three different Förster resonance energy transfer (FRET) based cAMP biosensors targeted to caveolin rich plasma membrane, SERCA and RyR microdomains, were crossed with PDE4B and PDE4D knockout mice. Using FRET imaging in ventricular cardiomyocytes freshly isolated from wildtype and knockout mice, direct analysis of the specific effect of both PDE subfamilies in these microdomains could be performed by measuring the kinetics of local cAMP degradation. Our results indicate that the cAMP kinetics around the LTCC microdomain is critically regulated by PDE4B and PDE4D. So far was it has been known that the isoform that is associated with the RyR microdomain belongs to the PDE4D family, however we found PDE4B to be involved in regulating the cAMP signaling in this microdomain. PDE4D deletion also revealed the critical role of this subfamily for the control of cAMP dynamics in the SERCA microdomain of adult mouse cardiomyocytes. Basal levels of cAMP were elevated when PDE4B was absent from any of the PDE4B-regulated microdomain, whereas no such alterations were detected for PDE4D knockout cells. These data demonstrate that all three microdomains are differentially regulated by PDEs. Even within one organelle such as sarcoplasmic reticulum, we could show the existence of at least two distinct cAMP microdomains, i.e. around RyR and SERCA which are preferentially controlled by PDE4B and PDE4D, respectively. In the future, we aim to systematically analyze biochemical composition of the three microdomains, their distinct roles in cardiac function and disease as well as ways of their pharmacological modulation.
Letter to the editor: Liver splitting during ex‐situ perfusion: Do not count your chickens before they are hatched…
Authors: Jean de Ville de Goyet, Olivier Boillot
Journal: Hepatology (2022)

To the editor, Rossignol et al. argue that ex‐situ splitting of livers (ESL) and during hypothermic oxygenated perfusion (HOPE) reduces cold preservation time (CPT)—a self‐contradiction.[1] They also hypothesize that non‐heart‐beating donor's livers (NHBD) could be used. Though clinical experimentation is a necessary tool in modern medicine, it should be run on a small scale until evidence of safety and reproducibility is provided. With not even a handful of cases done worldwide until now, ESL‐HOPE is at the experimental stage. The first case dates to 2020,[2] with both grafts transplanted in 2 children; both patients needed a relaparotomy (hemodynamic instability and bloody drainage). A second ESL‐HOPE was reported in early 2021 by Thorne et al.[2]: It was associated with 3.4 L of perioperative blood and needing a reoperation on day 3 for hematoma in the pediatric recipient and 6.2 L of perioperative blood loss in the adult recipient. Rossignol et al. referred to an initial experience with 2 ESL‐HOPE, with 1 left SLG recipient needing two relaparotomies for bleeding. All these preliminary reports call for attention; transplant teams should be made aware that: All donors met the criteria for standard splitting, and none were NHBD, nor even marginal. Severe hemorrhage seems a concern (observed in 5 of the 6 pediatric cases), likely secondary to ESL under perfusion of preservation fluid (not blood or plasma)—with little hemostasis other than mechanical (given that using electrocoagulation/CUSA [Cavitron Ultrasonic Surgical Aspirator] would alter/compromise the perfusion liquid) at the contrary of standard SLG procedures. Using single portal perfusion is a compromise with the HOPE concept, not consolidated, and should not be recommended for pediatric transplantation. CPT was not shorter, but similar to standard SLG CPT[3] and longer compared to that of in situ SLG[4] which should still be preferred. Though ESL‐HOPE and recipient operations in parallel in the same hospital may reduce CPT, short CPT <8 hours was achieved in a single case. A total of seven of eight transplants were performed in the ESL‐HOPE center, allowing favorable logistics unachievable in most organ‐sharing systems that apply the "sickest first" policy and not allowing the splitting center to benefit from the second graft outside the rules. Reproducibility of this strategy is a concern. Last, with standard in‐situ and ex‐situ techniques being well established and cost‐efficient, another concern is the cost/benefit ratio of ESL‐HOPE—at the current high costs. CONFLICT OF INTEREST Nothing to report. AUTHOR CONTRIBUTIONS Both authors participated in writing and/or reviewing the content and accepted the final manuscript.
Immunocompromised Patients with Acute Respiratory Failure: “Don’t Wait to Intubate”?
Authors: Peter Pickkers, Frank M. P. van Haren
Journal: American Journal of Respiratory and Critical Care Medicine (2021)

renal subscore.Again, although in some cases the adjusted scores were less poorly calibrated than the original score, differences in performance between Black and white patients remained.The results of these analyses suggest that other factors associated with Black versus white race were contributing to the calibration errors.This study is timely, of critical importance in the midst of the COVID-19 pandemic, and reinforces the necessity of examining each component of our public health and acute healthcare delivery systems for race-based disparities and inequities.The large size and multicenter nature of the population as well as the study's rigorous statistical approach and well-conceived sensitivity analyses are important strengths.However, the use of a non-COVID-19 patient population and the focus solely on mortality prediction scores rather than also evaluating full CSC scoring systems makes interpretation of these results in light of the pandemic or comparison to other studies, such as that by Gershengorn and colleagues (6), challenging.Given concerns that scoringsystems may be biased against nonwhite persons as well as the overwhelming evidence of higher prevalence and worse outcomes associated with COVID-19 among nonwhite communities, authors of some CSCs have proposed the use of correction factors that give credits to minoritized or disadvantaged groups.One example is the Area Deprivation Index, which uses a person's address to rank their degree of socioeconomic disadvantage (5, 8, 9), although this does not explicitly address the racial differences in calibration identified in thisstudy.TheuseofsuchcorrectionfactorsinCSCsisjustoneexampleof several potential approaches to address the systematic racial disparities identified by Dr. Ashana and colleagues.This important study highlights the crucial need for more research, validation, and refinement of CSC scoring systems to ensure that they achieve their goals of equitable distribution of resources while maximizing lives or life-years saved.
Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
Authors: Mark Bustoros, Chia-jen Liu, Kaitlen Reyes, Kalvis Hornburg, Kathleen Guimond, Rachel Styles, Alexandra Savell, Brianna Berrios, Diane Warren, Henry Dumke, Bradley Rivotto, Patrick Henrick, Emily Scranton, Houry Leblebjian, Kirsten Meid, Robert L. Schlossman, Nikhil Munshi, Jacob Laubach, Kenneth C. Anderson, Paul Richardson, Irene M. Ghobrial
Journal: Blood (2018)
Reduced myocardial functional reserve detected by ultra low-dose dobutamine in hypertensive patients with normal left ventricular function at rest Michaela Koz�kov�, Carlo Palombo, Simona Buralli, Armando Magagna, Carmela Morizzo, Alan Fraser, Antonio Salvetti. Department of Internal Medicine, University of Pisa, Pisa, Italy, University of Wales, Cardiology Department, Cardiff, United Kingdom
Journal: Journal of the American College of Cardiology (2001)
Nomogram to determine individualized estimates of screen-detected prostate cancer overdiagnosis
Journal: JNCI Journal of the National Cancer Institute (2014)

Nomogram to determine individualized estimates of screen-detected prostate cancer overdiagnosisUsing a nomogram that incorporates age, Gleason score, and prostate-specific antigen (PSA) level at diagnosis, individual risks that a screen-detected prostate cancer has been overdiagnosed can be estimated, according to a new study published January 6 in the Journal of the National Cancer Institute.
P-174 MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma: Trial in progress
Authors: J. Strickler, Y. Nakamura, K. Shitara, D. Catenacci, Y. Janjigian, A. Barzi, T. Bekaii-Saab, H. Lenz, J. Lee, E. Van Cutsem, H. Chung, J. Tabernero, T. Yoshino, S. Siena, J. Garrido-Mayor, M. Palanca-Wessels, D. Xie, J. Marshall
Journal: Annals of Oncology (2021)
Correction
Journal: BMJ (1950)

Local treatment would consist in keeping the meatus as clean as possible, and in ensuring that the discharge was allowed a free exit from the middle ear.The first object is attained either by syringing with warm water, followed by dry mopping, or by dry mopping alone, twice daily; the second by removal of granulations with chromic acid, of polypi by a snare, and of debris by syringe or scoop.
Intensification of local therapy with high-dose rate intraoperative radiation therapy (HDR-IORT) and extended resection for locally advanced and recurrent colorectal cancer.
Authors: Ryan Anthony Francisco Agas, Jennifer Tan, Sophia Xie, Sylvia Van Dyk, Alexander Graham Heriot, Samuel Y Ngan
Journal: Journal of Clinical Oncology (2022)

126 Background: This study reports our long-term experience with high dose rate intraoperative radiotherapy (HDR-IORT) in a single, quaternary institution. Methods: From 2004-2020, 138 consecutive patients with 141 total resections for locally advanced rectal cancer (LARC) (n=60, 43%) defined as T4Nx or T3N+ or locally recurrent rectal cancer (LRRC) (n=81, 57%) were retrospectively reviewed. The median age was 61 years (range 31-83) with 30 patients aged &gt;70 years during surgery. Most patients had preoperative radiotherapy (RT) +/- concurrent chemotherapy (n=125). Thirty-two recurrent cancers received preoperative pelvic reirradiation to a median dose of 36 Gy (range 34.2 – 41.4). HDR-IORT was delivered using isotope iridium-192 in a remote afterloader, and a Freiburg applicator, after macroscopic resection of the tumour. A single 10 Gy fraction was delivered. Fifty-eight of 84 patients who underwent pelvic exenterations had &gt;3 en bloc organs resected, and 96 patients underwent pelvic sidewall dissections. IORT sites included the primary tumour bed (33%), nodal regions (28%) and wider pelvic areas (70%). Resection margin status were R0 in 76 patients (54%) and R1 in 65 (46%). R1 resection was defined as positive (n=53) or close (n=12). R1 resection patients accounted for 61% of pelvic relapses. Results: With a median follow-up time of 4 years, 3-, 5-, and 7- year, overall survival (OS) rates were 75%, 48%, and 45%, respectively (84%,58%, 58% for LARC and 68%,39%, 35% for LRRC). Local progression-free survival (LPFS) of all patients were 88%, 85%, and 85%, respectively (97%, 93%, 93% for LARC and 80%, 80%, 80% for LRRC). On multivariable analysis, an R1 resection was associated with a trend toward poorer OS (p=0.05), while a trend towards worse LPFS (p=0.07) was noted for those without preoperative RT. The most common severe (grade ≥3) adverse events were postoperative abscess (n=25) and bowel obstruction (n=11). Overall, there were 49 (34%) grade 3-4 and no grade 5 adverse events. No intraoperative complications were attributed to IORT. The 30-day mortality rate was 0%. Conclusions: Favorable OS and LPFS can be achieved with intensive local therapy. As R1 resection may be associated with worse survival, optimisation of IORT, surgical resection, and systemic therapy are required. [Table: see text]
In Brief
Journal: JAMA (1976)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome
Authors: Xiaomin Liu, Xin Tong, Yuanqiang Zou, Xiaoqian Lin, Hui Zhao, Liu Tian, Zhuye Jie, Qi Wang, Zhe Zhang, Haorong Lu, Liang Xiao, Xuemei Qiu, Jin Zi, Rong Wang, Xun Xu, Huanming Yang, Jian Wang, Yang Zong, Weibin Liu, Yong Hou, Shida Zhu, Huijue Jia, Tao Zhang
Journal: Nature Genetics (2022)
Prodromes as predictors of hereditary angioedema attacks
Authors: Iris Leibovich‐Nassi, Avner Reshef, Raz Somech, Hava Golander
Journal: Allergy (2022)

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.